Advisor Group Holdings, Inc. Ocuphire Pharma, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $67.1 Billion
  • Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 13,904 shares of OCUP stock, worth $13,625. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,904
Previous 13,900 0.03%
Holding current value
$13,625
Previous $13,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
N/A
4 Added 0.03%
13,904 $13,000
Q2 2025

Sep 04, 2025
BUY
N/A
11,895 Added 593.27%
13,900 $13,000
Q2 2025

Aug 13, 2025
SELL
N/A
-23,400 Reduced 92.11%
2,005 $1,000
Q1 2025

May 12, 2025
BUY
N/A
11,505 Added 82.77%
25,405 $24,000
Q4 2024

Jun 06, 2025
SELL
$0.88 - $1.35 $10,124 - $15,531
-11,505 Reduced 45.29%
13,900 $13,000
Q4 2024

Feb 07, 2025
SELL
$0.88 - $1.35 $4 - $6
-5 Reduced 0.04%
13,900 $13,000
Q3 2024

Nov 13, 2024
SELL
$1.19 - $2.07 $9,103 - $15,835
-7,650 Reduced 35.49%
13,905 $18,000
Q2 2024

Aug 13, 2024
BUY
$1.51 - $2.23 $7,619 - $11,252
5,046 Added 30.57%
21,555 $32,000
Q1 2024

May 10, 2024
SELL
$1.89 - $3.27 $1,512 - $2,616
-800 Reduced 4.62%
16,509 $33,000
Q4 2023

Feb 12, 2024
SELL
$2.59 - $3.64 $10,942 - $15,379
-4,225 Reduced 19.62%
17,309 $52,000
Q3 2023

Nov 13, 2023
SELL
$3.35 - $4.33 $37,637 - $48,647
-11,235 Reduced 34.29%
21,534 $72,000
Q2 2023

Aug 10, 2023
BUY
$3.63 - $6.38 $118,875 - $208,932
32,748 Added 155942.86%
32,769 $142,000
Q1 2023

May 12, 2023
SELL
$3.01 - $3.85 $10,535 - $13,475
-3,500 Reduced 99.4%
21 $0
Q4 2022

Feb 10, 2023
BUY
$2.04 - $3.53 $7,084 - $12,259
3,473 Added 7235.42%
3,521 $12,000
Q3 2022

Nov 14, 2022
SELL
$1.82 - $2.79 $15,875 - $24,337
-8,723 Reduced 99.45%
48 $0
Q2 2022

Aug 10, 2022
BUY
$1.8 - $3.25 $15,750 - $28,437
8,750 Added 41666.67%
8,771 $17,000
Q1 2022

May 04, 2022
SELL
$2.75 - $4.39 $1,100 - $1,755
-400 Reduced 95.01%
21 $0
Q3 2021

Nov 05, 2021
BUY
$3.84 - $5.38 $1,536 - $2,152
400 Added 1904.76%
421 $2,000
Q1 2021

May 13, 2021
BUY
$5.7 - $13.31 $22 - $53
4 Added 23.53%
21 $0
Q4 2020

Feb 10, 2021
BUY
$3.76 - $8.8 $63 - $149
17 New
17 $0

Others Institutions Holding OCUP

# of Institutions
53
Shares Held
19.2M
Call Options Held
0
Put Options Held
0
View Full List

About Ocuphire Pharma, Inc.

OCUP Quotes by TradingView
  • Ticker OCUP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,579,800
  • Market Cap $20.2M
  • Description
  • Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...
More about OCUP
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email